Bi- and trispecific immune cell engagers for immunotherapy of hematological malignancies

Immune cell engagers are engineered antibodies with at least one arm binding a tumor-associated antigen and at least another one directed against an activating receptor in immune effector cells: CD3 for recruitment of T cells and CD16a for NK cells. The first T cell engager (the anti-CD19 blinatumom...

Descripción completa

Detalles Bibliográficos
Autores principales: Tapia-Galisteo, Antonio, Álvarez-Vallina, Luis, Sanz, Laura
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10373336/
https://www.ncbi.nlm.nih.gov/pubmed/37501154
http://dx.doi.org/10.1186/s13045-023-01482-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10373336/
https://www.ncbi.nlm.nih.gov/pubmed/37501154
http://dx.doi.org/10.1186/s13045-023-01482-w

Ejemplares similares